Clinical stage III melanoma, defined as resectable RECIST measurable nodal disease with or without in-transit metastases, represents approximately 15% of new melanoma diagnoses every year with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback